bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

bluebird bio   Receives EC Approval for  bluebird bio ( BLUE ) announced that the European Commission ( EC ) has granted marketing authorization of SKYSONA™ (elivaldogene autotemcel, Lenti-D™) one-tim...